- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Attune Pharmaceuticals Inc.
Headquarters: New York, NY, United States of America
Website: http://www.attunepharma.com
Year Founded: N/A
Status: Private
BioCentury | Feb 9, 2021
Product Development
KalVista gains on Phase II data for oral HAE treatment
KalVista gained $17.89 (114%) to $33.50 on Tuesday after reporting its oral on-demand protease inhibitor for HAE attacks met its primary endpoint of reducing the use of rescue medication.
BioCentury | Jan 25, 2019
Finance
Venrock spreads HAE bets
Why Venrock picked Attune for its latest oral HAE investment
BioCentury | Jan 25, 2019
Financial News
Attune raises $23M, reports safety data for angioedema candidate
BioCentury | Jan 23, 2019
Financial News
Attune raises $23M, reports safety data for angioedema candidate
Items per page:
1 - 4 of 4